Catalyst Wire Dossier Catalyst Wire Dossier

Tretinoin 0.02%

tretinoin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tretinoin 0.02%, covering 2013-08-20 to 2013-08-20. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles [Phase 2]

See pricing